BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Breast cancer AND JAK3, L-JAK, 3718, ENSG00000105639, P52333, JAKL, JAK-3, LJAK, JAK3_HUMAN
47 results:

  • 1. Construction of disulfidptosis-based immune response prediction model with artificial intelligence and validation of the pivotal grouping oncogene c-MET in regulating T cell exhaustion.
    Li P; Wang S; Wan H; Huang Y; Yin K; Sun K; Jin H; Wang Z
    Front Immunol; 2024; 15():1258475. PubMed ID: 38352883
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Integrated Safety Analysis of Ritlecitinib, an Oral jak3/TEC Family Kinase Inhibitor, for the Treatment of Alopecia Areata from the ALLEGRO Clinical Trial Program.
    King B; Soung J; Tziotzios C; Rudnicka L; Joly P; Gooderham M; Sinclair R; Mesinkovska NA; Paul C; Gong Y; Anway SD; Tran H; Wolk R; Zwillich SH; Lejeune A
    Am J Clin Dermatol; 2024 Mar; 25(2):299-314. PubMed ID: 38263353
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Design of a novel aptamer/molecularly imprinted polymer hybrid modified Ag-Au@Insulin nanoclusters/Au-gate-based MoS
    Mansouri Majd S; Mirzapour F; Shamsipur M; Manouchehri I; Babaee E; Pashabadi A; Moradian R
    Talanta; 2023 May; 257():124394. PubMed ID: 36858016
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Metformin inhibits the tumor-promoting effect of low-dose resveratrol, and enhances the anti-tumor activity of high-dose resveratrol by increasing its reducibility in triple negative breast cancer.
    Cheng T; Wang C; Lu Q; Cao Y; Yu W; Li W; Liu B; Gao X; Lü J; Pan X
    Free Radic Biol Med; 2022 Feb; 180():108-120. PubMed ID: 35038549
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Database Mining of Genes of Prognostic Value for the Prostate Adenocarcinoma Microenvironment Using the cancer Gene Atlas.
    Zhao X; Hu D; Li J; Zhao G; Tang W; Cheng H
    Biomed Res Int; 2020; 2020():5019793. PubMed ID: 32509861
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. [Janus kinase 3 facilitates the migration of breast cancer cells by store-operated calcium channel].
    Liu X; Wei T; Gao ZD; Zhao XL; Wu HQ; Yan J
    Sheng Li Xue Bao; 2019 Dec; 71(6):874-882. PubMed ID: 31879743
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Identification of differentially expressed lncRNAs and mRNAs in luminal-B breast cancer by RNA-sequencing.
    Yuan CL; Jiang XM; Yi Y; E JF; Zhang ND; Luo X; Zou N; Wei W; Liu YY
    BMC Cancer; 2019 Dec; 19(1):1171. PubMed ID: 31795964
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Intestinal breast cancer resistance protein (BCRP) requires Janus kinase 3 activity for drug efflux and barrier functions in obesity.
    Mishra J; Simonsen R; Kumar N
    J Biol Chem; 2019 Nov; 294(48):18337-18348. PubMed ID: 31653704
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. 21-Gene Recurrence Score and Adjuvant Chemotherapy Decision for breast cancer Patients with Positive Lymph Nodes.
    Tong Y; Wu J; Huang O; He J; Zhu L; Chen W; Li Y; Chen X; Shen K
    Sci Rep; 2019 Sep; 9(1):13123. PubMed ID: 31511599
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Application of Highly Immunocompromised Mice for the Establishment of Patient-Derived Xenograft (PDX) Models.
    Okada S; Vaeteewoottacharn K; Kariya R
    Cells; 2019 Aug; 8(8):. PubMed ID: 31412684
    [TBL] [Abstract] [Full Text] [Related]  

  • 11.
    Guerrero-Preston R; Lawson F; Rodriguez-Torres S; Noordhuis MG; Pirini F; Manuel L; Valle BL; Hadar T; Rivera B; Folawiyo O; Baez A; Marchionni L; Koch WM; Westra WH; Kim YJ; Eshleman JR; Sidransky D
    Cancer Prev Res (Phila); 2019 Apr; 12(4):255-270. PubMed ID: 30777857
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. SOCS3 overexpression enhances ADM resistance in bladder cancer T24 cells.
    Li MZ; Lai DH; Zhao HB; Chen Z; Huang QX; Situ J
    Eur Rev Med Pharmacol Sci; 2017 Jul; 21(13):3005-3011. PubMed ID: 28742207
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Circulating cell-free DNA-based epigenetic assay can detect early breast cancer.
    Uehiro N; Sato F; Pu F; Tanaka S; Kawashima M; Kawaguchi K; Sugimoto M; Saji S; Toi M
    Breast Cancer Res; 2016 Dec; 18(1):129. PubMed ID: 27993161
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Down-Regulation of Store-Operated Ca2+ Entry and Na+ Ca2+ Exchange in MCF-7 breast cancer Cells by Pharmacological jak3 Inhibition.
    Yan J; Zhang B; Hosseinzadeh Z; Lang F
    Cell Physiol Biochem; 2016; 38(4):1643-51. PubMed ID: 27119652
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Evaluation of the Effect of 1,3-Bis(4-Phenyl)-1H-1,2,3-Triazolyl-2-Propanolol on Gene Expression Levels of JAK2-STAT3, NF-κB, and SOCS3 in Cells Cultured from Biopsies of Mammary Lesions.
    Becerril JL; Benítez JG; Juárez JJ; Bañales JM; Zerón HM; Navarro MD
    Biochem Genet; 2015 Dec; 53(11-12):291-300. PubMed ID: 26315497
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Phosphatidic Acid Increases Epidermal Growth Factor Receptor Expression by Stabilizing mRNA Decay and by Inhibiting Lysosomal and Proteasomal Degradation of the Internalized Receptor.
    Hatton N; Lintz E; Mahankali M; Henkels KM; Gomez-Cambronero J
    Mol Cell Biol; 2015 Sep; 35(18):3131-44. PubMed ID: 26124282
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. MEK inhibition prevents tumour-shed transforming growth factor-β-induced T-regulatory cell augmentation in tumour milieu.
    Hossain DM; Panda AK; Chakrabarty S; Bhattacharjee P; Kajal K; Mohanty S; Sarkar I; Sarkar DK; Kar SK; Sa G
    Immunology; 2015 Apr; 144(4):561-73. PubMed ID: 25284464
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Screening and identification of small molecule inhibitors of ErbB2-induced invasion.
    Brix DM; Rafn B; Bundgaard Clemmensen K; Andersen SH; Ambartsumian N; Jäättelä M; Kallunki T
    Mol Oncol; 2014 Dec; 8(8):1703-18. PubMed ID: 25070180
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Capturing intra-tumor genetic heterogeneity by de novo mutation profiling of circulating cell-free tumor DNA: a proof-of-principle.
    De Mattos-Arruda L; Weigelt B; Cortes J; Won HH; Ng CKY; Nuciforo P; Bidard FC; Aura C; Saura C; Peg V; Piscuoglio S; Oliveira M; Smolders Y; Patel P; Norton L; Tabernero J; Berger MF; Seoane J; Reis-Filho JS
    Ann Oncol; 2014 Sep; 25(9):1729-1735. PubMed ID: 25009010
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Inhibition of STAT3 activation by KT-18618 via the disruption of the interaction between jak3 and STAT3.
    Shin DS; Jung SN; Yun J; Lee CW; Han DC; Kim B; Min YK; Kang NS; Kwon BM
    Biochem Pharmacol; 2014 May; 89(1):62-73. PubMed ID: 24607275
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 3.